$AXON
AXON ENTERPRISE, INC.

2024 Q3 Form 10-Q Financial Statement

#000106918324000049 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $544.3M $504.1M $374.6M
YoY Change 31.59% 34.57% 31.16%
Cost Of Revenue $213.5M $200.4M $142.5M
YoY Change 34.86% 40.62% 27.62%
Gross Profit $330.7M $303.7M $232.1M
YoY Change 29.57% 30.85% 33.43%
Gross Profit Margin 60.77% 60.25% 61.96%
Selling, General & Admin $192.2M $169.4M $119.9M
YoY Change 55.9% 41.28% 26.23%
% of Gross Profit 58.11% 55.78% 51.66%
Research & Development $114.5M $101.4M $71.94M
YoY Change 48.9% 41.0% 25.01%
% of Gross Profit 34.61% 33.4% 30.99%
Depreciation & Amortization $6.181M $13.00M $7.480M
YoY Change -26.42% 73.8% 20.45%
% of Gross Profit 1.87% 4.28% 3.22%
Operating Expenses $306.7M $270.9M $191.9M
YoY Change 53.21% 41.17% 25.77%
Operating Profit $24.08M $32.87M $40.26M
YoY Change -56.31% -18.34% 88.03%
Interest Expense $10.98M $9.782M -$52.37M
YoY Change -23.28% -118.68% -211.36%
% of Operating Profit 45.59% 29.76% -130.08%
Other Income/Expense, Net $44.51M $7.934M -$62.03M
YoY Change 1055.5% -112.79%
Pretax Income $79.57M $50.59M -$12.11M
YoY Change 14.61% -517.79% -117.69%
Income Tax $12.54M $9.793M -$24.53M
% Of Pretax Income 15.76% 19.36%
Net Earnings $67.03M $40.80M $12.42M
YoY Change 12.84% 228.48% -75.63%
Net Earnings / Revenue 12.31% 8.09% 3.32%
Basic Earnings Per Share $0.89 $0.54 $0.17
Diluted Earnings Per Share $0.86 $0.53 $0.16
COMMON SHARES
Basic Shares Outstanding 75.57M 75.47M 73.89M
Diluted Shares Outstanding 78.08M shares 77.55M 75.78M

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $846.7M $674.0M $539.0M
YoY Change 78.29% 25.05% 42.88%
Cash & Equivalents $695.1M $566.5M $474.2M
Short-Term Investments $151.6M $107.6M $64.80M
Other Short-Term Assets $117.6M $122.0M $101.6M
YoY Change 13.29% 20.14% 64.25%
Inventory $272.3M $277.8M $249.8M
Prepaid Expenses
Receivables $885.6M $729.5M $627.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.434B $2.206B $2.113B
YoY Change 7.79% 4.41% 80.6%
LONG-TERM ASSETS
Property, Plant & Equipment $235.9M $215.3M $179.1M
YoY Change 26.17% 20.23% 15.74%
Goodwill $308.5M $307.8M $57.74M
YoY Change 437.93% 433.0%
Intangibles $81.75M $85.57M $21.84M
YoY Change 302.22% 291.86%
Long-Term Investments $387.9M $363.1M $249.1M
YoY Change 61.43% 45.77% -18.75%
Other Assets $190.7M $227.8M $177.9M
YoY Change -1.97% 28.04% -13.09%
Total Long-Term Assets $1.572B $1.537B $964.8M
YoY Change 57.77% 59.28% 26.57%
TOTAL ASSETS
Total Short-Term Assets $2.434B $2.206B $2.113B
Total Long-Term Assets $1.572B $1.537B $964.8M
Total Assets $4.006B $3.742B $3.077B
YoY Change 23.09% 21.61% 59.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $75.59M $104.1M $72.99M
YoY Change -16.04% 42.59% 20.27%
Accrued Expenses $209.7M $141.6M $118.2M
YoY Change 42.71% 19.85% 24.96%
Deferred Revenue $505.0M $485.9M $412.2M
YoY Change 11.02% 17.87%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $823.2M $766.1M $625.2M
YoY Change 14.68% 22.53% 44.41%
LONG-TERM LIABILITIES
Long-Term Debt $679.5M $678.7M $675.5M
YoY Change 0.47% 0.47%
Other Long-Term Liabilities $20.53M $2.552M $2.843M
YoY Change 593.51% -10.24% -99.07%
Total Long-Term Liabilities $20.53M $2.552M $2.843M
YoY Change 593.51% -10.24% -99.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $823.2M $766.1M $625.2M
Total Long-Term Liabilities $20.53M $2.552M $2.843M
Total Liabilities $1.906B $1.814B $1.632B
YoY Change 9.97% 11.1% 121.08%
SHAREHOLDERS EQUITY
Retained Earnings $676.8M $605.3M $314.6M
YoY Change 80.98% 92.4%
Common Stock $1.588B $1.494B $1.293B
YoY Change 20.68% 15.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M $155.9M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $2.100B $1.929B $1.445B
YoY Change
Total Liabilities & Shareholders Equity $4.006B $3.742B $3.077B
YoY Change 23.09% 21.61% 59.28%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $67.03M $40.80M $12.42M
YoY Change 12.84% 228.48% -75.63%
Depreciation, Depletion And Amortization $6.181M $13.00M $7.480M
YoY Change -26.42% 73.8% 20.45%
Cash From Operating Activities $91.32M $82.76M $42.66M
YoY Change 45.18% 94.02% 120.15%
INVESTING ACTIVITIES
Capital Expenditures $26.47M $11.32M $13.20M
YoY Change 83.83% -14.25% -202.99%
Acquisitions
YoY Change
Other Investing Activities $69.54M $93.46M $167.1M
YoY Change -164.63% -44.08% -195.16%
Cash From Investing Activities $43.07M $82.14M $153.9M
YoY Change -135.3% -46.64% -181.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.713M -2.185M 14.26M
YoY Change 7.13% -115.32% -1627.19%
NET CHANGE
Cash From Operating Activities 91.32M 82.76M 42.66M
Cash From Investing Activities 43.07M 82.14M 153.9M
Cash From Financing Activities -7.713M -2.185M 14.26M
Net Change In Cash 126.7M 162.7M 210.9M
YoY Change -291.07% -22.83% -224.03%
FREE CASH FLOW
Cash From Operating Activities $91.32M $82.76M $42.66M
Capital Expenditures $26.47M $11.32M $13.20M
Free Cash Flow $64.85M $71.45M $29.46M
YoY Change 33.71% 142.54% -8.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001069183
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75573214
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75301424
us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16391
dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei City Area Code
CityAreaCode
480
dei Local Phone Number
LocalPhoneNumber
991-0797
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value
dei Trading Symbol
TradingSymbol
AXON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75574344
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
566452000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598545000
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
107550000
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
77940000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
402470000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
644054000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3258000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2392000
CY2024Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
386058000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
417690000
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
343422000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
275779000
CY2024Q2 us-gaap Inventory Net
InventoryNet
277753000
CY2023Q4 us-gaap Inventory Net
InventoryNet
269855000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
122033000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
112786000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2205738000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2396649000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
215324000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200533000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
226801000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
229513000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
85571000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19539000
CY2024Q2 us-gaap Goodwill
Goodwill
307758000
CY2023Q4 us-gaap Goodwill
Goodwill
57945000
CY2024Q2 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
3044000
CY2023Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
2588000
CY2024Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
107216000
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
77710000
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
363134000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
231730000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
227784000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
220638000
CY2024Q2 us-gaap Assets
Assets
3742370000
CY2023Q4 us-gaap Assets
Assets
3436845000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
104077000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88326000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
141614000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
188230000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
485869000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
491691000
CY2024Q2 axon Customer Deposit Current
CustomerDepositCurrent
23049000
CY2023Q4 axon Customer Deposit Current
CustomerDepositCurrent
21935000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11504000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9787000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
766113000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
799969000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
291424000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
281852000
CY2024Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
19008000
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
18049000
CY2024Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
14050000
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11342000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41705000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33550000
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
678678000
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
677113000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2552000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2936000
CY2024Q2 us-gaap Liabilities
Liabilities
1813530000
CY2023Q4 us-gaap Liabilities
Liabilities
1824811000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75573214
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75301424
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1493716000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1347410000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
20220227
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
20220227
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
605264000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
431249000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14194000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10679000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1928840000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1612034000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3742370000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3436845000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
504099000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
374605000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
964835000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717648000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200364000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
142484000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
401054000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
281425000
CY2024Q2 us-gaap Gross Profit
GrossProfit
303735000
CY2023Q2 us-gaap Gross Profit
GrossProfit
232121000
us-gaap Gross Profit
GrossProfit
563781000
us-gaap Gross Profit
GrossProfit
436223000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169427000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
119922000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
322096000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
236489000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101434000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71940000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192531000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142867000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
270861000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
191862000
us-gaap Operating Expenses
OperatingExpenses
514627000
us-gaap Operating Expenses
OperatingExpenses
379356000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
32874000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
40259000
us-gaap Operating Income Loss
OperatingIncomeLoss
49154000
us-gaap Operating Income Loss
OperatingIncomeLoss
56867000
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9782000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9663000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
20156000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
19329000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7934000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62031000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
147000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46421000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50590000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12109000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
216310000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29775000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9793000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-24529000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42295000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-27784000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
40797000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12420000
us-gaap Net Income Loss
NetIncomeLoss
174015000
us-gaap Net Income Loss
NetIncomeLoss
57559000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75511000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74224000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75433000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73435000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77550000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75780000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77346000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74834000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
40797000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12420000
us-gaap Net Income Loss
NetIncomeLoss
174015000
us-gaap Net Income Loss
NetIncomeLoss
57559000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2727000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-557000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3528000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1119000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
119000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-850000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
13000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-666000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38189000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11013000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
170500000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58012000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1612034000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-2710000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75115000
CY2024Q1 axon Adjustments To Additional Paid In Capital Replacement Awards Issued In Connection With Acquisitions
AdjustmentsToAdditionalPaidInCapitalReplacementAwardsIssuedInConnectionWithAcquisitions
1265000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
133218000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-907000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1818015000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-2185000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74821000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
40797000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2608000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1928840000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1268491000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33650000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-34841000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54346000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34350000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
45139000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1860000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1402995000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
61156000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-62214000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
157000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31891000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12420000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1407000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1444998000
us-gaap Profit Loss
ProfitLoss
174015000
us-gaap Profit Loss
ProfitLoss
57559000
us-gaap Share Based Compensation
ShareBasedCompensation
149936000
us-gaap Share Based Compensation
ShareBasedCompensation
66241000
us-gaap Gain Loss On Investments
GainLossOnInvestments
105386000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-46342000
axon Gain On Remeasurement Of Previously Held Minority Interest
GainOnRemeasurementOfPreviouslyHeldMinorityInterest
42313000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24564000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14169000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-8387000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-8036000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7755000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-37605000
axon Non Cash Lease Expense
NonCashLeaseExpense
3516000
axon Non Cash Lease Expense
NonCashLeaseExpense
2978000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1565000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1531000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
924000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
2867000
us-gaap Other Noncash Expense
OtherNoncashExpense
4165000
us-gaap Other Noncash Expense
OtherNoncashExpense
1457000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
60513000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
102205000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8116000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
43585000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
4252000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
49290000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-43071000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-35976000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12067000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
69886000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66825000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13667000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
414361000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
246049000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
664358000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
381082000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27512000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21650000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
34000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
187000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
76628000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
10917000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
237796000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21026000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91905000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
81256000
axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
94806000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54503000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4895000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
97055000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4895000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52254000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2086000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
806000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32061000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
120649000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
600670000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355552000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
568609000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
476201000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
566452000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
474203000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2157000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1998000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
568609000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
476201000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
47399000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
25052000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5299000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
750000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
40797000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12420000
us-gaap Net Income Loss
NetIncomeLoss
174015000
us-gaap Net Income Loss
NetIncomeLoss
57559000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75511000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74224000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75433000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73435000
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1334000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1556000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1289000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1399000
CY2024Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
705000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
624000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77550000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75780000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77346000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74834000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10106000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6163000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10188000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6169000
axon Warranty Period After Purchase Of Product
WarrantyPeriodAfterPurchaseOfProduct
P1Y
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7374000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
811000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3672000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
514000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1813000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3143000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5515000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3440000
CY2024Q2 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
8100000
CY2023Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
7600000
CY2024Q2 axon Debt Instrument Principal Amount Denomination For Fair Value Calculation
DebtInstrumentPrincipalAmountDenominationForFairValueCalculation
1000
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
2200000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
2100000
CY2024Q2 axon Restricted Cash Including Prepaid Expenses And Other Assets
RestrictedCashIncludingPrepaidExpensesAndOtherAssets
2100000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
504099000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
374605000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
964835000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717648000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
504099000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
374605000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
964835000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717648000
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
450638000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
777293000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
327266000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
485869000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
291424000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
777293000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
491691000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
281852000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
773543000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
485869000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
291424000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
777293000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
491691000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
281852000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
773543000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7400000000
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1059333000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
17552000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
413000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1076472000
CY2024Q2 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
566452000
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
107550000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
402470000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
345500000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
345500000
CY2024Q2 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerUnrealizedLosses
14900000
CY2024Q2 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Gross Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerGrossUnrealizedLosses
100000
CY2024Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
7800000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
29600000
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
10000000.0
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
25600000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1333022000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
158000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12641000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1320539000
CY2023Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
598545000
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
77940000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
644054000
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
420400000
CY2023Q4 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerUnrealizedLosses
138800000
CY2023Q4 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Gross Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerGrossUnrealizedLosses
300000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3966000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2241000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
470000
axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
-15000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5752000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3258000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2392000
CY2024Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2445000
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1516000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
49000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
44000
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
14000
CY2024Q2 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
5752000
CY2023Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3966000
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
110839000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
104112000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
166914000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
165743000
CY2024Q2 us-gaap Inventory Net
InventoryNet
277753000
CY2023Q4 us-gaap Inventory Net
InventoryNet
269855000
CY2023Q4 us-gaap Goodwill
Goodwill
57945000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
250653000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
425000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-415000
CY2024Q2 us-gaap Goodwill
Goodwill
307758000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
110570000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26788000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
83782000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42978000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25282000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17696000
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1789000
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1789000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1843000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1843000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
112359000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26788000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
85571000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
44821000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25282000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19539000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6900000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7679000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12532000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12335000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
11394000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
11283000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
11099000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
17460000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
83782000
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
295497000
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
CY2024Q2 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
67500000
CY2023Q2 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
10917000
CY2024Q2 axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
21000
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
137000
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
73843000
CY2024Q2 axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
-21000
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
363134000
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
233637000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
231730000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
76628000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
10917000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
45183000
axon Equity Securities Without Readily Determinable Fair Value Loss On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueLossOnSaleOfSecurities
2870000
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
75776000
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
73843000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
-63313000
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
363134000
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
233637000
CY2024Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
42300000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
222581000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
57495000
axon Equity Securities Without Readily Determinable Fair Value Loss On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueLossOnSaleOfSecurities
2870000
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
179666000
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
84009000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
4817000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
363134000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66854000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125636000
CY2024Q2 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
20975000
CY2023Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
12197000
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
12816000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5784000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6544000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7377000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5515000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7374000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28910000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29862000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
141614000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
188230000
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
226800000
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
26300000
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
26300000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
6600000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
axon Effective Income Tax Rate Reconciliation Estimate Before Discrete Adjustments
EffectiveIncomeTaxRateReconciliationEstimateBeforeDiscreteAdjustments
0.229
axon Effective Income Tax Rate Reconciliation Deduction Stockbased Compensation
EffectiveIncomeTaxRateReconciliationDeductionStockbasedCompensation
7500000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
74821000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
31891000
us-gaap Share Based Compensation
ShareBasedCompensation
149936000
us-gaap Share Based Compensation
ShareBasedCompensation
66241000
CY2024Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2
axon Product Claims Self Insurance
ProductClaimsSelfInsurance
5000000.0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
504099000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
374605000
CY2024Q2 axon Adjusted Gross Margins
AdjustedGrossMargins
315228000
CY2023Q2 axon Adjusted Gross Margins
AdjustedGrossMargins
233799000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8517000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1678000
CY2024Q2 axon Amortization Of Acquired Technology Intangible Assets
AmortizationOfAcquiredTechnologyIntangibleAssets
2976000
CY2024Q2 us-gaap Gross Profit
GrossProfit
303735000
CY2023Q2 us-gaap Gross Profit
GrossProfit
232121000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169427000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
119922000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101434000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71940000
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9782000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9663000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7934000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62031000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50590000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12109000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
964835000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717648000
axon Adjusted Gross Margins
AdjustedGrossMargins
606555000
axon Adjusted Gross Margins
AdjustedGrossMargins
439221000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38112000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2998000
axon Amortization Of Acquired Technology Intangible Assets
AmortizationOfAcquiredTechnologyIntangibleAssets
4662000
us-gaap Gross Profit
GrossProfit
563781000
us-gaap Gross Profit
GrossProfit
436223000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
322096000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
236489000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192531000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142867000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
20156000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
19329000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
147000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46421000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
216310000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29775000
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
900000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4400000
CY2024Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
42300000
CY2024Q1 us-gaap Goodwill
Goodwill
250000000.0
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
72900000
CY2024Q1 axon Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Excluding Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesExcludingDeferredTaxLiabilities
7800000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y6M

Files In Submission

Name View Source Status
axon-20240630_cal.xml Edgar Link unprocessable
axon-20240630_pre.xml Edgar Link unprocessable
0001069183-24-000049-index-headers.html Edgar Link pending
0001069183-24-000049-index.html Edgar Link pending
0001069183-24-000049.txt Edgar Link pending
0001069183-24-000049-xbrl.zip Edgar Link pending
axon-20240630.xsd Edgar Link pending
axon-20240630x10q.htm Edgar Link pending
axon-20240630xex10d4.htm Edgar Link pending
axon-20240630xex10d4001.jpg Edgar Link pending
axon-20240630xex31d1.htm Edgar Link pending
axon-20240630xex31d2.htm Edgar Link pending
axon-20240630xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
axon-20240630x10q_htm.xml Edgar Link completed
axon-20240630_lab.xml Edgar Link unprocessable
axon-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending